FACTOR DE TRANSFERENCIA: ¿REAL O FAKE? | MR DOCTOR скачать в хорошем качестве

FACTOR DE TRANSFERENCIA: ¿REAL O FAKE? | MR DOCTOR

¡SUSCRIBETE Y ACTIVA LAS NOTIFICACIONES! Hoy hablaremos sobre el #FactorDeTransferencia en esta nueva sección llamada: #RealoFake ¡COMENTA, COMPARTE Y DALE LIKE A ESTE VIDEO! CONTACTO MR DOCTOR E-MAIL: MrDoctorOficial@gmail.com TELEFONO: 2223349545 UBICACIÓN: HOSPITAL MAC PUEBLA: CONSULTORIO 1406 REDES SOCIALES #MrDoctor​​​​​​​​​​​ Instagram:   / mrdoctoroficial   Facebook:   / mrdoctoroficial1   Twitter:   / mrdoctoroficial   TIK TOK: MrDoctorOf OTROS VÍDEOS QUE TE PUEDEN INTERESAR: MEDICO PRUEBA HERBALIFE    • MÉDICO PRUEBA HERBALIFE *TERMINA MAL* | ¿A...   BIOMAGNETISMO    • REACCIONANDO A CHARLATANES: BIOMAGNETISMO ...   DIOXIDO DE CLORO    • MITOS DEL DIÓXIDO DE CLORO | MEDICO LO ACL...   BIBLIOGRAFIA PAGINA DE TRANSFERON https://factordetransferenciaipn.mx/t... PAGINA DEL INSTITUTO POLITECNICO NACIONAL https://www.ipn.mx/imageninstituciona... MAS FUENTES BIBLIOGRAFICAS 1. Chase MW. The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc Soc Exp Biol Med 1945;59:34. 2. Chase MW. The cellular transfer of cutaneous hypersensitivity. J Bacteriol 1946;51:643. 3. Lawrence HS. The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc Soc Exp Biol Med 1949;71:516. 4. Urbach F, Sones MIH. Passive transfer of tuberculin sensitivity to patients with sarcoidosis. N Engl J Med 1952;247:794. 5. Lawrence HS. The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci. J Immunol 1952;68:159e178. 6. Lawrence HS. The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes. J Clin Invest 1955;34:219e230. 7. Avery OT, Mccarty M, MacLeod CM. Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types. J Exp Med 1944;79:137e158. 8. Rozzo SJ, Kirkpatrick CH. Purification of transfer factors. Mol Immunol 1992;29:167e182. 9. Levin AS, Spitler LE, Stites DP, et al. Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor. Proc Natl Acad Sci 1970;67:821e828. 10.- . Bullock WE, Fields JP, Brandriss MW. An Evaluation of Transfer Factor as Immunotherapy for Patients with Lepromatous Leprosy. N Engl J Med 1972;287:1053e1059. 11. Fabre RA, Perez TM, Aguilar LD, et al. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol 2004;136:215e223. 12. Lawrence HS, Borkowsky W. Transfer factor — Current status and future prospects. Biotherapy 1996;9:1e5. 13. Burger DR, Vandenbark AA, Daves D, et al. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. J Immunol 1976;117:797e801. 14. Borkowsky W, Lawrence HS. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay. J Immunol 1979;123:1741e1748. 15. Lawrence HS, Borkowsky W. A new basis for the immunoregulatory activities of transfer factor-An arcane dialect in the language of cells. Cell Immunol 1983;82:102e116. 16. Kirkpatrick CH. Structural Nature and Functions of Transfer Factors. Ann N Y Acad Sci 1993;685:362e368. 17. Kirkpatrick CH. Transfer Factors: Identification of Conserved Sequences in Transfer Factor Molecules. Mol Med 2000;6:332e341. 18. Sinha SK, Sizemore RC, Gottlieb AA. Immunomodulatory Components Present in IMREG-1, an Experimental Immunosupportive Biologic. Biotechnology 1988;6:810e815. 19. Sizemore RC, Kern CH, Gottlieb MS, et al. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: A measure of the immunopotentiation of cell-mediated immunity. Clin Immunol Immunopathol 1995;76:308e313. 20. Medina-Rivero E, Vallejo-Castillo L, Vazquez-Leyva S, et al. Physicochemical Characteristics of TransferonTM Batches. Biomed Res Int 2016;7935181:1e8. 21. Myles IA, Zhao M, Nardone G, et al. CD8 þ T cells produce a dialyzable antigen-specific activator of dendritic cells. J Leukoc Biol 2017;101:307e320. 22. Wilson GB, Metcalf JF, Fudenberg HH. Treatment of Mycobacterium fortuitum pulmonary infection with ‘‘transfer factor’’ (TF): New methodology for evaluating TF potency and predicting clinical response. Clin Immunol Immunopathol 1982;23:478e491. 23. Nishihira J. Macrophage Migration Inhibitory Factor (MIF): Its Essential Role in the Immune System and Cell Growth. J Interferon Cytokine Res 2000;20:751e762. 24. Bach JP, Deuster O, Balzer-Geldsetzer M, et al. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 2009;115:2031e2040. 25. Estrada-Parra S, Nagaya A, Serrano E, et al. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int J Immunopharmacol 1998;20:521e535.